1. European Glaucoma Society Terminology and Guidelines for Glaucoma (4^th Edition). Savona: PubliComm, 2014: 196.

2. Национальное руководство по глаукоме для практикующих врачей. Изд. 4-е, испр. и доп. / Под ред. Е.А. Егорова, В.П. Еричева. М.: ГЭОТАР-Медиа, 2019: 384.

3. World Glaucoma Association Consensus Statement: Angle Closure and Angle Closure Glaucoma / Eds. Weinreb R.N., Friedman D.S. The Netherlands: Kluger; 2006: 113.

4. Primary Angle Closure / American Academy of Ophthalmology Preferred Practice Pattern(R) Guidelines, San Francisco; 2015: 40.

5. Seah S.K., Foster P.J., Chew P.T. et al. Incidence of acute primary angle-closure glaucoma in Singapore. An island-wide survey. Arch Ophthalmol. 1997; 115(11): 1436 - 1440.

6. Foster P.J., Baasanhu J., Alsbirk P.H. et al. Glaucoma in Mongolia. A population-based survey in Hovsgol province, northern Mongolia. Arch Ophthalmol. 1996; 114(10): 1235 - 1241.

7. Bengtsson B. The prevalence of glaucoma. Br J Ophthalmol. 1981; 65(1): 46 - 49.

8. Wolfs R.C., Grobbee D.E., Hofman A., de Jong P.T. Risk of acute angle-closure glaucoma after diagnostic mydriasis in nonselected subjects: the Rotterdam Study. Invest Ophthalmol Vis Sci. 1997; 38(12): 2683 - 2687.

9. Congdon N., Wang F., Tielsch J.M. Issues in the Epidemiology and Population-Based Screening of Primary Angle-Closure Glaucoma. Surv Ophthalmol. 1992; 36(6): 411 - 423.

10. Lai J.S., Liu D.T., Tham C.C. et al. Epidemiology of acute primary angle-closure glaucoma in the Hong Kong Chinese population: prospective study. Hong Kong Med J. 2001; 7(2): 118 - 123.

11. Perkins E.S. Family studies in glaucoma. Br J Ophthalmol. 1974; 58(5): 529 - 535.

12. Leighton D.A. Survey of the first-degree relatives of glaucoma patients. Trans Ophthalmol Soc UK. 1976; 96(1): 28 - 32.

13. Ефимова М.Н. Злокачественная глаукома: диагностика, клиника, лечение. Глаукома. 2002; 1: 53 - 60.

14. Quigley H.A., Friedman D.S., Congdon N.G. Possible mechanisms of primary angle-closure and malignant glaucoma. J Glaucoma 2003; 12(2): 167 - 180.

15. Yue B.Y., Duvall J., Goldberg M.F. et al. Nanophthalmic sclera; morphologic and tissue culture studiem. Ophtalmology. 1986; 93(4): 534 - 541.

16. Resnikoff S., Pascolini D., Etyaale D. et al. Global data on visual impairment in the year 2002. WHO Bull. 2004; 82(11): 844 - 855.

17. Quigley H.A., Broman A.T. The number of persons with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006; 90(3): 262 - 267.

18. Dandona L., Dandona R., Mandal P. et al. Angle closure glaucoma in an urban population in southern India. The Andhra Pradesh eye disease study. Ophthalmology. 2000; 107(9): 1710 - 1716.

19. Jacob A., Thomas R., Koshi S.P. et al. Prevalence of primary glaucoma in an urban south Indian population. Ind J Ophthalmol. 1998; 46(2): 81 - 86.

20. Ramakrishnan R., Nirmalan P.K., Krishnadas R. et al. Glaucoma in a rural population of southern India: the Aravind comprehensive eye survey. Ophthalmology. 2003; 110(8): 1484 - 1490.

21. Vijaya L., George R., Arvind H. et al. Prevalence of angle-closure disease in a rural southern Indian population. Arch Ophthalmol. 2006; 124(3): 403 - 409.

22. Shiose Y., Kitazawa Y., Tsukuhara S. et al. Epidemiology of glaucoma in Japan - A nationwide glaucoma survey. Jpn J Ophthalmol. 1991; 35(2): 133 - 135.

23. Foster P.J., Baasanhu J., Alsbrik P.H. et al. Glaucoma in Mongolia - A poplation-based survey in Hovsgol Province, Northern Mongolia. Arc Ophthalmol. 1996; 114(10): 1235 - 1241.

24. Foster P.J., Oen F.T., Machin D.S. et al.The prevalence of glaucoma in Chinese residents of Singapore. A cross-sectional population survey in Tanjong Pagar district. Arch Ophthalmol. - 2000; 118(8): 1105 - 1111.

25. Yamamoto T., Iwase A., Araie M., et al. The Tajimi Study report 2: prevalence of primary angle closure and secondary glaucoma in a Japanese population. Ophthalmology. 2001; 112(10): 1661 - 1669.

26. Foster P.J., Jonson G.J. Glaucoma in China: how big is the problem? Br J Ophthalmol. 2001; 85(11): 1277 - 1282.

27. Alsbirk P.H. Primary angle closure glaucoma. Oculometry, epidemiology, and genetics in a high risk population. Acta Ophthalmol. 1976; 127: 5 - 31.

28. Bourne R.A., Sukudom P., Foster P.J. et al. Prevalence of glaucoma in Thailand: a population based survey in Rom Klao District, Bangkok. Br J Ophthalmol. 2003; 87(9): 1069 - 1074.

29. Foster P.J., Buhrmann R., Quigley H.A., Johnson G.J. The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol. 2002; 86(2): 238 - 242.

30. Day A.C., Baio G., Gazzard G., et al. The prevalence of primary angle closure glaucoma in European derived populations: a systematic review. Br J Ophthalmol. 2012; 96(9): 1162 - 1167.

31. Общая заболеваемость взрослого населения России в 2018 году: Статистические материалы. Часть IV. [Электронный ресурс]. М.: 2019: 45 - 46. URL: https://www.rosminzdrav.ru/ministry/61/22/stranitsa-979/statisticheskie-informatsionnye-materialy/statisticheskiy-sbornik-2018-god (дата обращения: 20.04.2020)

32. Clinical decisions in glaucoma / E. Hodapp, R. Parrish, D. Anderson // St. Louis: The CV Mosby Co. 1993: 204.

33. Shah N.N., Bowd C., Medeiros F.A. et al. Combining structural and functional testing for detection of glaucoma. Ophthalmology. 2006; 113(9): 1593 - 1602.

34. Coleman A., Friedman D., Gandolfi S., Singh K., Tuulonen A. Levels of diagnostic studies. In Weinreb R.N., Greve E.L. (Eds.) / Glaucoma diagnosis: Structure and Function. Consensus series I. Amsterdam: Kugler Puplications. 2004: 9 - 12.

35. Alsbirk P.H. Early detection of primary angle-closure glaucoma. Limbal and axial chamber depth screening in a high risk population (Greenland Eskimos). Acta Ophthalmol. 1988; 66(5): 556 - 564.

36. Wilensky J.T., Kaufman P.L., Frohlichstein D. et al. Follow-up of angle-closure glaucoma suspects. Am J Ophthalmol. 1993; 115(3): 338 - 346.

37. Alsbirk P.H. Anatomical risk factors in primary angle-closure glaucoma. A ten-year follow-up survey based on limbal and axial anterior chamber depths in a high risk population. Int Ophthalmol. 1992; 16(4-5): 265 - 272.

38. Thomas R., George R., Parikh R. et al. Five year risk of progression of primary angle closure suspects to primary angle closure: a population based study. Br J Ophthalmol. 2003; 87(4): 450 - 454.

39. Amerasinghe N., Zhang J., Thalamuthu A. et al.The heritability and sibling risk of angle closure in Asians. Ophthalmology. 2011; 118(3): 480 - 485.

40. Lowe R.F. Aetiology of the anatomical basis for primary angle-closure glaucoma. Biometrical comparisons between normal eyes and eyes with primary angle-closure glaucoma. Br J Ophthalmol. 1970; 54(3): 161 - 169.

41. Congdon N.G., Quigley H.A., Hung P.T. et al. Screening techniques for angleclosure glaucoma in rural Taiwan. Acta Ophthalmol. 1996; 74(2): 113 - 119.

42. Wong T.Y., Foster P.J., Seah S.K., Chew P.T. Rates of hospital admissions for primary angle closure glaucoma among Chinese, Malays, and Indians in Singapore. Br J Ophthalmol. 2000; 84(9): 990 - 992.

43. Salmon J.F. Predisposing factors for chronic angle-closure glaucoma. Prog Retin Eye Res. 1999; 18(1): 121 - 132.

44. Lowe R.F. Acute angle-closure glaucoma. The second eye: an analysis of 200 cases. Br J Ophthalmol. 1962; 46(11): 641 - 650.

45. Subak-Sharpe I., Low S., Nolan W., Foster P.J. Pharmacological and environmental factors in primary angle-closure glaucoma. Br Med Bull. 2010; 93: 125 - 143.

46. Kong X., Chen Y., Chen X., Sun X. Influence of family history as a risk factor on primary angle closure and primary open angle glaucoma in a Chinese population. Ophthalmic Epidemiol. 2011; 18(5): 226 - 232.

47. Lachkar Y., Bouassida W. Drug-induced acute angle closure glaucoma. Curr. Opin. Ophthalmol. 2007; 18(2): 129 - 133.

48. Li J., Tripathi R.C., Tripathi B.J. Drug-induced ocular disorders. Drug Safety. 2008; 31(2): 127 - 141.

49. Wojciechowski R., Congdon N., Anninger W., Broman A.T. Age, gender, biometry, refractive error, and the anterior chamber angle among Alaskan Eskimos. Ophthalmology. 2003; 110(2): 365 - 375.

50. Kumar R.S., Tantisevi V., Wong M.H. et al. Plateau iris in Asian subjects with primary angle closure glaucoma. Arch Ophthalmol. 2009; 127(10): 1269 - 1272.

51. van Herick W., Shaffer R.N., Schwartz A. Estimation of width of angle of anterior chamber. Incidence and significance of the narrow angle. Am J Ophthalmol. 1969; 68(4): 626 - 629.

52. Lavanya R., Foster P.J., Sakata L.M. et al. Screening for narrow angles in the Singapore population: evaluation of new noncontact screening methods. Ophthalmology. 2008; 115(10): 1720 - 1727.

53. Bengtsson B., Leske M.C., Hyman L., Heijl A. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial. Ophthalmology. 2007; 114(2): 205 - 209.

54. Caprioli J., Coleman A.L. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study. Ophthalmology. 2008; 115(7): 1123 - 1129.

55. Bengtsson B., Heijl A. Diurnal IOP fluctuation: not an independent risk factor for glaucomatous visual field loss in high-risk ocular hypertension. Graefes Arch Clin Exp Ophthalmol. 2005; 243(6): 513 - 518.

56. Leske M.C., Heijl A., Hyman L. et al. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology. 2007; 114(11): 1965 - 1972.

57. Thomas R., George T., Braganza A., Muliyil J. The flashlight test and Van Herick's test are poor predictors for occludable angles. Aust N Z J Ophthalmol. 1996; 24(3): 251 - 256.

58. Foster P.J., Devereux J., Alsbirk P.H. et al. Detection of gonioscopically occludable angles and primary angle-closure glaucoma by estimation of limbal chamber depth in Asians: Modified grading scheme. Br J Ophthalmol. 2000; 84(2): 186 - 192.

59. Devereux J.G., Foster P.J., Baasanhu J. et al. Anterior chamber depth measurement as a screening tool for primary angle-closure glaucoma in an East Asian population. Arch Ophthalmol. 2000; 118(2): 257 - 263.

60. Spaeth G.L. The normal development of the human anterior chamber angle: a new system of descriptive grading. Trans. Ophthalmol. Soc. (UK). 1971; 91: 709 - 739.

61. Shaffer R.N. Gonioscopy anatomy of the angle of the anterior chamber of the eye. In. SRe, ed. In: Stereoscopic manual of gonioscopy. St. Louis, Mosby. 1962: 97.

62. Kanski JS, M. Glaukom In: Kanski J. SMe, ed. In: Lehrbuch der klinischen Ophthalmologie Stuttgart, New York Thieme, 1987.

63. Primary Open-Angle Glaucoma. Preferred Practice Pattern(R) Guidelines. San Francisco, CA: American Academy of Ophthalmology, 2015: 41 - 111.

64. Lin S.C., Singh K., Jampel H.D. et al. Optic nerve head and retinal nerve fiber layer analysis: a report by the American Academy of Ophthalmology. Ophthalmology. 2007; 114(10): 1937 - 1949.

65. Keltner J.L., Johnson C.A., Levine R.A. et al. Normal visual field test results following glaucomatous visual field end points in the Ocular Hypertension Treatment Study. Arch. Ophthalmol. 2005; 123(9): 1201 - 1206.

66. Chauhan B.C., McCormick T.A., Nicolela M.T., LeBlanc R.P. Optic disc and visual field changes in a prospective longitudinal study of patients with glaucoma: comparison of scanning laser tomography with conventional perimetry and optic disc photography. Arch Ophthalmol. 2001; 119(10): 1492 - 1499.

67. Miglior S., Zeyen T., Pfeiffer N. et al. Group. Results of the European Glaucoma Prevention Study / European Glaucoma Prevention Study (EGPS). Ophthalmology. 2005; 112(3): 366 - 375.

68. Aghaian E., Choe J.E., Lin S., Stamper R.L. Central corneal thickness of Caucasians, Chinese, Hispanics, Filipinos, African Americans, and Japanese in a glaucoma clinic. Ophthalmology. 2004; 111(12): 2211 - 2219.

69. Rahman M.L., Bunce C., Healey P.R. et al. Commingling analyses of central corneal thickness and adjusted intraocular pressure in an older Australian population. Invest Ophthalmol. Vis Sci. 2010; 51(5): 2512 - 2518.

70. Dueker D.K., Singh K., Lin S.C. et al. Corneal thickness measurement in the management of primary open-angle glaucoma: a report by the American Academy of Ophthalmology. Ophthalmology. 2007; 114(9): 1779 - 1787.

71. Medeiros F.A., Sample P.A., Zangwill L.M. et al. Corneal thickness as a risk factor for visual field loss in patients with preperimetric glaucomatous optic neuropathy. Am. J. Ophthalmol. 2003; 136(9): 805 - 813.

72. Kotowski J., Wollstein G., Ishikawa H., Schuman J.S. Imaging of the optic nerve and retinal nerve fiber layer: an essential part of glaucoma diagnosis and monitoring. Surv Ophthalmol. 2014; 59(4): 458 - 467.

73. Leung C.K. Diagnosing glaucoma progression with optical coherence tomography. Curr Opin Ophthalmol. 2014; 25(2): 104 - 111.

74. Miglior S., Zeyen T., Pfeiffer N. et al. Results of the European Glaucoma Prevention Study / European Glaucoma Prevention Study (EGPS) Group. Ophthalmology. 2005; 112(3): 366 - 375.

75. Lalezary M., Medeiros F.A., Weinreb R.N. et al. Baseline optical coherence tomography predicts the development of glaucomatous change in glaucoma suspects. Am. J. Ophthalmol - 2006; 142(4): 576 - 582.

76. Friedman D.S., He M. Anterior chamber angle assessment techniques. Surv Ophthalmol. 2008; 53(3): 250 - 273.

77. Foster P.J., Alsbirk P.H., Baahanhu J. et al. Anterior chamber depth in Mongolians. Variation with age, sex and method of measurement. Am J Ophthalmology. 1997; 124(1): 53 - 60.

78. Kaushik S., Jain R., Pandav S.S., Gupta A. Evaluation of the anterior chamber angle in Asian Indian eyes by ultrasound biomicroscopy and gonioscopy. Indian J Ophthalmol. 2006; 54(3): 159 - 163.

79. Nolan W.P., See J.L., Chew P.T. et al. Detection of primary angle closure using anterior segment optical coherence tomography in Asian eyes. Ophthalmology. 2007; 114(1): 33 - 39.

80. Wong H.T., Lim M.C., Sakata L.M. et al. High-definition optical coherence tomography imaging of the iridocorneal angle of the eye. Arch Ophthalmol. 2009; 127(3): 256 - 260.

81. Baskaran M., Ho S.W., Tun T.A. et al. Assessment of circumferential angle-closure by the iris-trabecular contact index with swept-source optical coherence tomography. Ophthalmology. 2013; 120(11): 2226 - 2231.

82. Guidelines for Glaucoma Eye Care. International Council of Ophthalmology. San Francisco, California. 2015: 20 p.

83. Kobayashi H., Kobayashi K., Kiryu J., Kondo T. Pilocarpine induces an increase in the anterior chamber angular width in eyes with narrow angles. Br J Ophthalmol. 1999; 83(5): 553 - 558.

84. Medical Treatment of Glaucoma / Eds. Weinreb R.N., Araie A., Susanna R. et al. Kluger Publication. 2010: 310 p.

85. Day A., Nolan W., Malik A., Viswanathan A., Foster P. Pilocarpine induced acute angle closure. BMJ Case Rep. 2012; 8: 56.

86. Wand M., Grant W. M., Simmons R. J., Hutchinson B. T. Plateau iris syndrome. Trans. Sect. Ophthalmol. Am Acad. Ophthalmol. Otolaryngol. 1977; 83(1): 122 - 130.

87. Hui X., Michelessi M. Medical interventions for treating primary angle-closure glaucoma. Cochrane Database Syst Rev. 2015; 12: CD012001.

88. Hoyng P.F., van Beek L.M. Pharmacological therapy for glaucoma: a review. Drugs. 2000; 59(3): 411 - 434.

89. Ramani K.K., Mani B., George R.J., Lingam V. Follow-up of primary angle closure suspects after laser peripheral iridotomy using ultrasound biomicroscopy and A-scan biometry for a period of 2 years. J Glaucoma. 2009; 18(7): 521 - 527.

90. Jaenen N., Baudouin C., Pouliquen P. et al. Ocular symptoms and signs with preserved and preservative free glaucoma medications. Eur. J, Ophthalmol. 2007; 17(3): 341 - 349.

91. Olthoft C.M., Schuten J.S., Van de Borne B.W., Webers C.A. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review. Ophthalmology. 2005; 112(6): 953 - 961.

92. Patel S.C., Spaeth G.L. Compliance in patients prescribed eye drops for glaucoma. Ophthalmic Surg. 1995; 26(3): 233 - 236.

93. Serle J.B., Toor A., Fahim M.M. et al. The effect of Varying Dosing Interval on the Efficacy of Intraocular Pressure Lowering Drugs. Invest. Ophthalmol Vis Sci. 2004; 45(5): 971.

94. Higginbotham E.J. Considerations in glaucoma therapy: fixed combinations versus their component medications. Clin Ophthalmol. 2010; 4: 1 - 9.

95. Cox J.A., Mollan S.P., Bankart J., Robinson R. Efficacy of antiglaucoma fixed combination therapy versus unfixed components in reducing intraocular pressure: a systematic review. Br J Ophthalmol. 2008; 92(6): 729 - 734.

96. Pisella P.J., Pouliquen P., Baudouin C. Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. Br J Ophthalmol. 2002; 86(4): 418 - 423.

97. Vaideanu D., Fraser S. Glaucoma management in pregnancy: a questionnaire survey. Eye (Lond). 2007; 21(3): 341 - 343.

98. Madadi P., Koren G., Freeman D.J. et al. Timolol concentrations in breast milk of a woman treated for glaucoma: calculation of neonatal exposure. J. Glaucoma. 2008; 17(4): 329 - 331.

99. Ho J.D., Hu C.C., Lin H.C. Antiglaucoma medications during pregnancy and the risk of low birth weight: a population-based study. Br J Ophthalmol. 2009; 93(10): 1283 - 1286.

100. Lowe R.F. Acute angle closure glaucoma: acetazolamide therapy. Aust J Ophthalmol. 1973; 1(1): 24 - 26.

101. Choong Y.F., Irfan S., Menage M.J. Acute angle closure glaucoma: an evaluation of a protocol for acute treatment. Eye (Lond). 1999; 13(5): 613 - 616.

102. Ramli N., Chai S.M., Tan G.S. et al. Efficacy of medical therapy in the initial management of acute primary angle closure in Asians. Eye (Lond). 2010; 24(10): 1599 - 1602.

103. Chan P.P., Pang J.C., Tham C.C. Acute primary angle closure-treatment strategies, evidences and economical considerations. Eye (Lond). 2019; 33(1): 110 - 119.

104. Anderson D.R. Corneal indentation to relieve acute angle-closure glaucoma. Am J Ophthalmol. 1979; 88(6): 1091 - 1093.

105. Foreman-Larkin J., Netland P., Salim S. Clinical Management of Malignant Glaucoma. J Ophthalmol. 2015; 2015: 283707.

106. Shen C.J., Chen Y.Y., Sheu S.J. Treatment course of recurrent malignant glaucoma monitoring by ultrasound biomicroscopy: a report of two cases. Kaohsiung J Med Sci. 2008; 24(11): 608 - 613.

107. Cordeiro M.F., Levin L.A. Clinical evidence for neuroprotection in glaucoma. Am J Ophthalmol. 2011; 152(5): 715 - 716.

108. Sena D.F., Lindsley K. Neuroprotection for treatment of glaucoma in adults. Cochrane Database Syst Rev. 2013; 28(2): CD006539.

109. Krupin T., Liebmann J.M., Greenfield D.S. et al. A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study Am J Ophthalmol. 2011; 151(4): 671 - 681.

110. Radhakrishnan S., Chen P.P., Junk A.K., Nouri-Mahdavi K., Chen T.C. Laser Peripheral Iridotomy in Primary Angle Closure: A Report by the American Academy of Ophthalmology. Ophthalmology. 2018; 125(7): 1110 - 1120.

111. He M., Jiang Y., Huang S. et al. Laser peripheral iridotomy for the prevention of angle closure: a single-centre, randomised controlled trial. Lancet. 2019; 393(10181): 1609 - 1618.

112. Le J.T., Rouse B., Gazzard G. Iridotomy to slow progression of visual field loss in angle-closure glaucoma. Cochrane Database Syst Rev. 2018; 6: CD012270.

113. Sihota R., Rishi K., Srinivasan G. et al. Functional evaluation of an iridotomy in primary angle closure eyes. Graefes Arch Clin Exp Ophthalmol. 2016; 254(6): 1141 - 1149.

114. Dada T., Mohan S., Sihota R. et al. Comparison of ultrasound biomicroscopic parameters after laser iridotomy in eyes with primary angle closure and primary angle closure glaucoma. Eye (Lond). 2007; 21(7): 956 - 961.

115. Pearce F.C., Thomas R., Wong N.J., Walland M.J. Long-term progression after laser peripheral iridotomy in Caucasian primary angle closure suspects. Clin Exp Ophthalmol. 2018; 46, (7): 828 - 830.

116. Yip J.L., Foster P.J., Uranchimeg D. et al. Randomised controlled trial of screening and prophylactic treatment to prevent primary angle closure glaucoma. Br J Ophthalmol. 2010; 94(11): 1472 - 1477.

117. Yuen N.S., Cheung P., Hui S.P. Comparing brimonidine 0,2% to apraclonidine 1,0% in the prevention of intraocular pressure elevation and their pupillary effects following laser peripheral iridotomy. Jpn J Ophthalmol. 2005; 49(2): 89 - 92.

118. Ng W.S., Ang G.S., Azuara-Blanco A. Laser peripheral iridoplasty for angle-closure. Cochrane Database Syst Rev. 2012; 2: CD006746.

119. Chee W.K., Srinivasan S., Cheng J. Lasers IN PRIMARY ANGLE CLOSURE. US Ophthalmic Review. 2015; 8(2): 99 - 102.

120. Jiang Y., Chang D.S., Foster P.J. et al. Immediate changes in intraocular pressure after laser peripheral iridotomy in primary angle-closure suspects. Ophthalmology. 2012; 119(2): 283 - 288.

121. Chen T.C. Brimonidine 0,15% versus apraclonidine 0.5% for prevention of intraocular pressure elevation after anterior segment laser surgery. J Cataract Refract Surg. 2005; 31(9): 1707 - 1712.

122. Nolan W.P., Foster P.J., Devereux J.G. et al. YAG laser iridotomy treatment for primary angle-closure in East Asian eyes. Br J Ophthalmol. 2000; 84(11): 1255 - 1259.

123. de Silva D.J., Gazzard G., Foster P. Laser iridotomy in dark irides. Br J Ophthalmol. 2007; 91(2): 222 - 225.

124. Peng D., Zhang X., Yu K. Argon laser peripheral iridoplasty and laser iridoectomy for plateau iris glaucoma. Zhonghua Yan Ke Za Zhi. 1997; 33(3): 165 - 168.

125. Liebmann J.M., Ritch R. Laser surgery for angle closure glaucoma. Semin Ophthalmol. 2002; 17(2): 84 - 91.

126. Narayanaswamy A., Leung C.K., Istiantoro D.V. et al. Efficacy of selective laser trabeculoplasty in primary angle-closure glaucoma: a randomized clinical trial. JAMA Ophthalmol. 2015; 133(2): 206 - 212.

127. Ali Aljasim L., Owaidhah O., Edward D.P. Selective Laser Trabeculoplasty in Primary Angle-closure Glaucoma After Laser Peripheral Iridotomy: A Case-Control Study. J Glaucoma. 2016; 25(3): 253 - 258.

128. Barnes S.D., Campagna J.A., Dirks M.S., Doe E.A. Control of intraocular pressure elevations after argon laser trabeculoplasty: comparison of brimonidine 0,2% to apraclonidine 1,0% Ophthalmology. 1999; 106(10): 2033 - 2037.

129. Dastiridou A., Katsanos A., Denis P., Francis B., Mikropoulos D., Teus M, Konstas A. Cyclodestructive Procedures in Glaucoma: A Review of Current and Emerging Options. Adv Ther. 2018; 35(12): 2103 - 2127.

130. Murphy C.C., Burnett C.A., Spry P.G. et al. A two-centre study of the dose-response relation for transscleral diode laser cyclophotocoagulation in refractory glaucoma. Br J Ophthalmol. 2003; 87(10): 1252 - 1257.

131. Chen M.F., Kim C.H., Coleman A.L. Cyclodestructive procedures for refractory glaucoma. Cochrane Database Syst Rev. 2019; 10(3): CD012223.

132. Berke S.J. Cyclophotocoagulation in Glaucoma Management. Endolaser Tech Opthalmol. 2006; 4(2): 74 - 81.

133. Tan A.M., Chockalingam M., Aquino M.C. et al. Micropulse transscleral diode laser cyclophotocoagulation in the treatment of refractory glaucoma. Clin Exp Ophthalmol. 2010; 38(3): 266 - 272.

134. Sihota R., Gupta V., Agarwal H.C. Long-term evaluation of trabeculectomy in primary open angle glaucoma and chronic primary angle closure glaucoma in an Asian population. Clin Exp Ophthalmol. 2004; 32(1): 23 - 28.

135. Chen Y.H., Lu D.W., Cheng J.H. et al. Trabeculectomy in patients with primary angle-closure glaucoma. J Glaucoma. 2009; 18(9): 679 - 683.

136. Aung T., Tow S.L., Yap E.Y. et al. Trabeculectomy for acute primary angle closure. Ophthalmology. 2000; 107(7): 1298 - 1302.

137. Dhingra S., Khaw P.T. The Moorfields safer surgery system. Middle East Afr. J. Ophthalmol. 2009; 16(3): 112 - 115.

138. Koukkoulli A., Musa F., Anand N. Long-term outcomes of needle revision of failing deep sclerectomy blebs. Graefes Arch Clin Exp Ophthalmol. 2015; 253(1): 99 - 106.

139. Rotchford A.P., King A.J. Needling revision of trabeculectomies bleb morphology and long-term survival. Ophthalmology. 2008; 115(7): 1148 - 1153.

140. Lam D.S., Leung D.Y., Tham C.C. et al. Randomized trial of early phacoemulsification versus peripheral iridotomy to prevent intraocular pressure rise after acute primary angle closure. Ophthalmology. 2008; 115(7): 1134 - 1140.

141. Shams P.N., Foster P.J. Clinical outcomes after lens extraction for visually significant cataract in eyes with primary angle closure. J Glaucoma. 2012; 21(8): 545 - 550.

142. Husain R., Gazzard G., Aung T. et al. Initial management of acute primary angle closure: a randomized trial comparing phacoemulsification with laser peripheral iridotomy. Ophthalmology. 2012; 119(11): 2274 - 2281.

143. Azuara-Blanco A., Burr J., Ramsay C. et al. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. / EAGLE study group. Lancet. 2016; 388(1): 1389 - 1397.

144. Faucher A., Hasanee K., Rootman D.S. Phacoemulsification and intraocular lens implantation in nanophthalmic eyes. Report of a medium-size series. J Cataract Refract Surg. 2002; 28(5): 837 - 842.

145. Roberts T.V., Francis I.C., Lertusumitkul S. et al. Primary phacoemulsification for uncontrolled angle-closure glaucoma. J Cataract Refract Surg. 2000; 26(7): 1012 - 1016.

146. Hayashi K., Hayashi H., Nakao F., Hayashi F. Changes in anterior chamber angle width and depth after intraocular lens implantation in eyes with glaucoma. Ophthalmology. 2000; 107(4): 698 - 703.

147. Lai J.S., Tham C.C., Chan J.C., Lam D.S. Phacotrabeculectomy in treatment of primary angleclosure glaucoma and primary open-angle glaucoma. Jpn J Ophthalmol. 2004; 48(4): 408 - 411.

148. Tow S.L.C, Aung T., Oen F.T.S., Seah S.K.L. Combined phacoemulsification, intraocular lens implantation and trabeculectomy in Asian patients with chronic angle closure glaucoma. Int Ophthalmol. 2001; 24(5): 283 - 289.

149. Tham C.C., Kwong Y.Y., Leung D.Y. et al. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Ophthalmology. 2009; 116(4): 725 - 7231.

150. Friedman D., Vedula S.S. Lens extraction for chronic angle-closure glaucoma (Review) Cochrane Database Syst Rev. 2006; 3: CD005555

151. Gunning F.P., Greve E.L. Lens extraction for uncontrolled glaucoma. J Cataract Refract Surg. 1998; 24(10): 1347 - 1356.

152. Hansapinyo L., Choy B.N.K., Lai J.S.M., Tham C.C. Phacoemulsification Versus Phacotrabeculectomy in Primary Angle-closure Glaucoma With Cataract: Long-Term Clinical Outcomes. J Glaucoma. 2020; 29(1): 15 - 23.

153. Sharma A., Sii F., Shah P., Kirkby G.R. Vitrectomy-phacoemulsification-vitrectomy for the management of aqueous misdirection syndromes in phakic eyes. Ophthalmology. 2006; 113(11): 1968 - 1973.

154. Francis B.A., Babel D. Malignant glaucoma (aqueous misdirection) after pars plana vitrectomy. Ophthalmology. 2000; 107(7): 1220 - 1222.

155. Seah S.K.L., Gazzard G., Aung T. Intermediate-term Outcome of Baerveldt Glaucoma Implants in Asian Eyes. Ophthalmology. 2003; 110(5): 888 - 894.

156. Chung A.N., Aung T., Wang J.C., Chew P.T.K. Surgical outcomes of combined phacoemulsification and glaucoma drainage implant surgery for Asian patients with refractory glaucoma and cataract. Am J Ophthalmol. 2004; 137(2): 294 - 300.

157. Glaucoma surgery: Treatment and Techniques / Eds. Carreti L., Burrato L. Milan: Springer; 2018: 132.

158. Jampel H.D., Friedman D.S., Lubomski L.H. et al. Effect of technique on intraocular pressure after combined cataract and glaucoma surgery: an evidence-based review. Ophthalmology. 2002; 109(12): 2215 - 2224.

159. Than J.Y.L., Al-Mugheiry T.S., Gale J., Martin K.R. Factors predicting the success of trabeculectomy bleb enhancement with needling. Br J Ophthalmol. 2018; 102(12): 1667 - 1671.

160. Ali M., Akhtar F. Ocular digital massage for the management of post-trabeculectomy underfiltering blebs. J Coll Physicians Surg Pak. 2011; 21(11): 676 - 679.

161. Tuulonen A. Economic considerations of the diagnosis and management for glaucoma in the developed world. Curr Opin Ophthalmol. 2011; 22(2): 102 - 109.

162. Ervin A.M., Boland M.V., Myrowitz E.H. et al. Rockville (MD): Screening for Glaucoma: Comparative Effectiveness. 2012; 4: 12-EHC037-EF.

163. Taylor H.R., Crowston J., Keeffe J. et al. Tunnel vision: the economic impact of primary open angle glaucoma - a dynamic economic model. Melbourne: Centre for Eye Research Australia, 2008. www.cera.org.au

164. "Об утверждении порядка проведения профилактического медицинского осмотра и диспансеризации определенных групп взрослого населения". Приказ Минздрава России N 124н от 13.03.2019 https://www.rosminzdrav.ru/poleznye-resursy/dispanserizatsiya (дата обращения 20.04.2020)

165. Ang L.P., Aung T., Chew P.T. Acute primary angle closure in an Asian population: long-term outcome of the fellow eye after prophylactic laser peripheral iridotomy. Ophthalmology. 2000; 107(11): 2092 - 2096.

166. Edwards R.S. Behaviour of the fellow eye in acute angle-closure glaucoma. Br J Ophthalmol. 1982; 66(9): 576 - 579.

167. Wilensky J.T., Kaufman P.L., Frohlichstein D. et al. Follow-up of angle-closure glaucoma suspects. Am J Ophthalmol. 1993; 115(3): 338 - 346.

168. Saw S.M., Gazzard G., Friedman D.S. Interventions for angle-closure glaucoma: an evidence-based update. Ophthalmology. 2003; 110(10): 1869 - 1878.

169. Snow J.T. Value of prophylactic peripheral iridectomy on the second eye in angle-closure glaucoma. Trans Ophthalmol Soc UK. 1977; 97(1): 189 - 191.

170. Морозов В.И., Яковлев А.А. Фармакотерапия глазных болезней: Справочник. - Изд. 4-е, перераб. и доп. - М.: Медицина, 2001. - 472 с.

171. Орлова А.С., Башкатов А.Н., Генина Э.А. и соавт. Влияние 40%-го раствора глюкозы на структуру роговицы человека. Известия Саратовского университета. Новая серия. Серия Физика. 2014; 14(1): 11 - 19.

172. Wu L. L. et al. A 12-week, double-masked, parallel-group study of the safety and efficacy of travoprost 0.004% compared with pilocarpine 1% in Chinese patients with primary angle-closure and primary angle-closure glaucoma //Journal of glaucoma. - 2011. - T. 20. - N. 6. - С. 388 - 391.